Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022132178> ?p ?o ?g. }
- W2022132178 endingPage "1284" @default.
- W2022132178 startingPage "1281" @default.
- W2022132178 abstract "<b><i>Background:</i></b> The initial studies on nitrosoureas were performed >30 years ago. These drugs remain the standard chemotherapy for glioblastoma. However, because the criteria used to evaluate the activity of nitrosoureas in a neuro-oncologic setting have changed, new data on their activity are needed. <b><i>Methods:</i></b> The authors conducted a phase II study on 40 patients with recurrent glioblastoma following surgery and standard radiotherapy. They analyzed progression-free survival at 6 months (PFS-6), time to progression (TTP), response rate, and toxicity. Patients were treated with 80 mg/m<sup>2</sup> carmustine on days 1 to 3, every 8 weeks for a maximum of six cycles. <b><i>Results:</i></b> Median TTP was 13.3 weeks (95% CI, 10.26 to 16.86 weeks), and PFS-6 was 17.5% (95% CI, 8.9 to 34.3). Response to chemotherapy, age ≤40 years, and performance status ≥90 were significant prognostic factors for TTP; however, with multivariate analysis, only response to chemotherapy was significant. The major side effects were reversible hematologic and long-lasting hepatic and pulmonary toxicity. <b><i>Conclusion:</i></b> The activity of this BCNU regimen is comparable with that reported in the past and with the newest therapies, such as temozolomide. However, BCNU toxicity is high and recovery is slow, thus compromising the administration of further drugs in patients with progressive disease." @default.
- W2022132178 created "2016-06-24" @default.
- W2022132178 creator A5019091770 @default.
- W2022132178 creator A5022934821 @default.
- W2022132178 creator A5023634468 @default.
- W2022132178 creator A5047678826 @default.
- W2022132178 creator A5050067769 @default.
- W2022132178 creator A5066862718 @default.
- W2022132178 creator A5082916894 @default.
- W2022132178 date "2004-10-11" @default.
- W2022132178 modified "2023-10-11" @default.
- W2022132178 title "How effective is BCNU in recurrent glioblastoma in the modern era?: A phase II trial" @default.
- W2022132178 cites W1508981216 @default.
- W2022132178 cites W1970510435 @default.
- W2022132178 cites W1974210709 @default.
- W2022132178 cites W1977392502 @default.
- W2022132178 cites W199447113 @default.
- W2022132178 cites W2029409133 @default.
- W2022132178 cites W2098708609 @default.
- W2022132178 cites W2102651437 @default.
- W2022132178 cites W2113647927 @default.
- W2022132178 cites W2125643269 @default.
- W2022132178 cites W2139745787 @default.
- W2022132178 cites W2156310984 @default.
- W2022132178 doi "https://doi.org/10.1212/01.wnl.0000140495.33615.ca" @default.
- W2022132178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15477552" @default.
- W2022132178 hasPublicationYear "2004" @default.
- W2022132178 type Work @default.
- W2022132178 sameAs 2022132178 @default.
- W2022132178 citedByCount "125" @default.
- W2022132178 countsByYear W20221321782012 @default.
- W2022132178 countsByYear W20221321782013 @default.
- W2022132178 countsByYear W20221321782014 @default.
- W2022132178 countsByYear W20221321782015 @default.
- W2022132178 countsByYear W20221321782016 @default.
- W2022132178 countsByYear W20221321782017 @default.
- W2022132178 countsByYear W20221321782018 @default.
- W2022132178 countsByYear W20221321782019 @default.
- W2022132178 countsByYear W20221321782020 @default.
- W2022132178 countsByYear W20221321782021 @default.
- W2022132178 countsByYear W20221321782022 @default.
- W2022132178 crossrefType "journal-article" @default.
- W2022132178 hasAuthorship W2022132178A5019091770 @default.
- W2022132178 hasAuthorship W2022132178A5022934821 @default.
- W2022132178 hasAuthorship W2022132178A5023634468 @default.
- W2022132178 hasAuthorship W2022132178A5047678826 @default.
- W2022132178 hasAuthorship W2022132178A5050067769 @default.
- W2022132178 hasAuthorship W2022132178A5066862718 @default.
- W2022132178 hasAuthorship W2022132178A5082916894 @default.
- W2022132178 hasConcept C126322002 @default.
- W2022132178 hasConcept C141071460 @default.
- W2022132178 hasConcept C143998085 @default.
- W2022132178 hasConcept C2776694085 @default.
- W2022132178 hasConcept C2776755627 @default.
- W2022132178 hasConcept C2776946711 @default.
- W2022132178 hasConcept C2777389519 @default.
- W2022132178 hasConcept C2778336483 @default.
- W2022132178 hasConcept C2779429289 @default.
- W2022132178 hasConcept C2779434656 @default.
- W2022132178 hasConcept C2780147359 @default.
- W2022132178 hasConcept C2780739268 @default.
- W2022132178 hasConcept C2781413609 @default.
- W2022132178 hasConcept C29730261 @default.
- W2022132178 hasConcept C31760486 @default.
- W2022132178 hasConcept C509974204 @default.
- W2022132178 hasConcept C71924100 @default.
- W2022132178 hasConcept C90924648 @default.
- W2022132178 hasConceptScore W2022132178C126322002 @default.
- W2022132178 hasConceptScore W2022132178C141071460 @default.
- W2022132178 hasConceptScore W2022132178C143998085 @default.
- W2022132178 hasConceptScore W2022132178C2776694085 @default.
- W2022132178 hasConceptScore W2022132178C2776755627 @default.
- W2022132178 hasConceptScore W2022132178C2776946711 @default.
- W2022132178 hasConceptScore W2022132178C2777389519 @default.
- W2022132178 hasConceptScore W2022132178C2778336483 @default.
- W2022132178 hasConceptScore W2022132178C2779429289 @default.
- W2022132178 hasConceptScore W2022132178C2779434656 @default.
- W2022132178 hasConceptScore W2022132178C2780147359 @default.
- W2022132178 hasConceptScore W2022132178C2780739268 @default.
- W2022132178 hasConceptScore W2022132178C2781413609 @default.
- W2022132178 hasConceptScore W2022132178C29730261 @default.
- W2022132178 hasConceptScore W2022132178C31760486 @default.
- W2022132178 hasConceptScore W2022132178C509974204 @default.
- W2022132178 hasConceptScore W2022132178C71924100 @default.
- W2022132178 hasConceptScore W2022132178C90924648 @default.
- W2022132178 hasIssue "7" @default.
- W2022132178 hasLocation W20221321781 @default.
- W2022132178 hasLocation W20221321782 @default.
- W2022132178 hasOpenAccess W2022132178 @default.
- W2022132178 hasPrimaryLocation W20221321781 @default.
- W2022132178 hasRelatedWork W1974699748 @default.
- W2022132178 hasRelatedWork W1988630830 @default.
- W2022132178 hasRelatedWork W2008163333 @default.
- W2022132178 hasRelatedWork W2019602455 @default.
- W2022132178 hasRelatedWork W2025359066 @default.
- W2022132178 hasRelatedWork W2062669800 @default.
- W2022132178 hasRelatedWork W2084871044 @default.
- W2022132178 hasRelatedWork W2109684315 @default.